Literature DB >> 7488776

Comparison of fresh and glutaraldehyde-treated autologous stented pericardium as pulmonary valve replacement.

S P Kumar1, G Prabhakar, M Kumar, N Kumar, M Shahid, M L Ali, A Becker, C M Duran.   

Abstract

The use of fresh autologous pericardium in valve surgery has shown poor results in the past mainly due to thickening and retraction. Recently, it has been suggested that a short treatment with glutaraldehyde might radically change its behavior. In an attempt to determine whether this disparity in results is due to the glutaraldehyde treatment or to a better present-day surgical technique, fresh and glutaraldehyde-treated autologous pericardium was mounted in a frame and implanted in the pulmonary position of adult sheep. Six survivors obtained in each group were sacrificed between 2 and 8 months in the "fresh" group and between 2 and 6 months in the "glutaraldehyde-treated" group. Macroscopically, the fresh pericardium became thickened and retracted in all specimens, eventually resulting in severe regurgitation, while the glutaraldehyde-treated, although slightly thickened, retained its pliability without significant retraction. Microscopically, viability of the central core of the collagen was more often preserved in the fresh pericardium. Endothelialization was irregular. In conclusion, short glutaraldehyde treatment seems to improve the results of autologous pericardium mounted on a valve stent. Its effect on calcification remains to be ascertained.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488776     DOI: 10.1111/j.1540-8191.1995.tb00630.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  2 in total

1.  Aortic valve replacement with autologous pericardium: long-term follow-up of 15 patients and in vivo histopathological changes of autologous pericardium.

Authors:  Xiaohong Liu; Lin Han; Zhigang Song; Mengwei Tan; Dejun Gong; Zhiyun Xu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-08

2.  Reinforced pericardium as a hybrid material for cardiovascular applications.

Authors:  Laura G Bracaglia; Li Yu; Narutoshi Hibino; John P Fisher
Journal:  Tissue Eng Part A       Date:  2014-11       Impact factor: 3.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.